IRIS
MONTORSI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 36.495
NA - Nord America 19.751
EU - Europa 16.124
SA - Sud America 11.822
AF - Africa 882
OC - Oceania 114
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 1
Totale 85.213
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.757
SG - Singapore 15.511
BR - Brasile 9.920
CN - Cina 8.835
HK - Hong Kong 5.707
SE - Svezia 4.497
IT - Italia 3.725
VN - Vietnam 3.157
RU - Federazione Russa 2.417
DE - Germania 1.147
RO - Romania 817
AR - Argentina 788
FI - Finlandia 719
IN - India 681
GB - Regno Unito 570
ID - Indonesia 503
CA - Canada 412
NL - Olanda 387
MX - Messico 358
EC - Ecuador 350
IE - Irlanda 337
BD - Bangladesh 323
JP - Giappone 288
ZA - Sudafrica 266
IQ - Iraq 265
FR - Francia 241
TR - Turchia 237
ES - Italia 225
PL - Polonia 222
AT - Austria 219
CO - Colombia 209
PY - Paraguay 156
UA - Ucraina 149
PK - Pakistan 127
MA - Marocco 120
EG - Egitto 110
CL - Cile 108
VE - Venezuela 107
UZ - Uzbekistan 99
AU - Australia 89
PE - Perù 80
IR - Iran 75
SA - Arabia Saudita 74
UY - Uruguay 67
KE - Kenya 66
LT - Lituania 66
TN - Tunisia 64
AE - Emirati Arabi Uniti 62
NG - Nigeria 61
DZ - Algeria 52
NP - Nepal 52
JO - Giordania 51
DO - Repubblica Dominicana 50
AZ - Azerbaigian 48
CH - Svizzera 48
BE - Belgio 41
MY - Malesia 41
IL - Israele 39
KZ - Kazakistan 39
KR - Corea 34
TW - Taiwan 33
BG - Bulgaria 29
CZ - Repubblica Ceca 29
GR - Grecia 29
JM - Giamaica 27
BO - Bolivia 25
AL - Albania 24
HN - Honduras 24
OM - Oman 22
RS - Serbia 22
BH - Bahrain 21
NO - Norvegia 21
PH - Filippine 20
TH - Thailandia 20
KW - Kuwait 19
LB - Libano 19
PA - Panama 19
PT - Portogallo 18
SN - Senegal 18
BA - Bosnia-Erzegovina 17
CR - Costa Rica 17
TT - Trinidad e Tobago 17
GT - Guatemala 16
SV - El Salvador 16
TZ - Tanzania 16
BY - Bielorussia 15
DK - Danimarca 15
PS - Palestinian Territory 15
BB - Barbados 14
XK - ???statistics.table.value.countryCode.XK??? 14
HU - Ungheria 13
NZ - Nuova Zelanda 13
SC - Seychelles 13
HR - Croazia 12
ET - Etiopia 11
AO - Angola 10
KG - Kirghizistan 10
MK - Macedonia 10
AM - Armenia 9
CI - Costa d'Avorio 9
Totale 84.986
Salva come PNG Salva come JPEG
Città #
Singapore 6.040
Hong Kong 5.672
Dallas 4.974
Hefei 2.271
Shanghai 2.233
Lawrence 2.119
Princeton 2.113
Ashburn 2.016
Ho Chi Minh City 1.211
Moscow 1.081
Milan 835
New York 784
São Paulo 774
Beijing 749
Hanoi 652
Helsinki 535
Los Angeles 498
Rio de Janeiro 338
Dublin 332
Munich 291
Boardman 278
Rome 262
Belo Horizonte 210
Nuremberg 203
Brasília 189
Warsaw 172
Tokyo 170
Brooklyn 164
Pune 162
Curitiba 154
Montreal 152
Santa Clara 145
Porto Alegre 136
Denver 135
Johannesburg 134
Guangzhou 132
Turku 132
Haiphong 130
Campinas 124
Orem 123
Chennai 122
Da Nang 117
Atlanta 114
The Dalles 114
Guayaquil 112
Quito 110
Stockholm 107
Vienna 106
Seattle 104
Biên Hòa 102
Turin 101
Columbus 100
Guarulhos 99
London 96
Poplar 96
Salvador 96
Chicago 92
Washington 91
Thái Bình 90
Boston 88
Jakarta 87
Phoenix 87
Toronto 86
Ribeirão Preto 85
Tashkent 84
Houston 82
Tianjin 81
Baghdad 79
Mexico City 79
Naples 78
Frankfurt am Main 76
Hangzhou 76
Hải Dương 76
Goiânia 73
Manaus 73
Manchester 72
Recife 72
Fortaleza 71
Bologna 70
Caxias do Sul 66
Dhaka 66
Mumbai 65
Amsterdam 64
Ankara 64
Buenos Aires 64
Santo André 61
Sumaré 61
Florence 60
Council Bluffs 59
Valencia 59
Istanbul 58
Osasco 58
Ninh Bình 56
San Francisco 54
Montevideo 53
Sorocaba 53
Cape Town 51
Erbil 51
Lima 50
Nairobi 50
Totale 43.592
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.634
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.361
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis 466
Benign Prostatic Hyperplasia and Its Aetiologies 424
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers 373
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 342
High serum alpha-fetoprotein levels in primary infertile men 330
Women's sexual dysfunction: a pathophysiological review 278
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 179
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 174
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 163
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 148
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 138
Organic vs. Psychogenic? The Manichean Diagnosis in Sexual Medicine 134
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 132
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 126
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 123
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 113
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 112
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 110
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 108
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 107
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 107
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 106
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 106
120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION 105
Nasal congestion after visual sexual stimulation with and without sildenafil (Viagra (R)): a randomized placebo-controlled study 104
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 104
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 104
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 104
Sildenafil taken at bedtime significantly increases nocturnal erections: Results of a placebo-controlled study 103
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 102
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 102
A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) 101
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 101
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 100
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 100
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 100
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 100
4-DRUG INTRACAVERNOUS THERAPY FOR IMPOTENCE DUE TO CORPOREAL VENOOCCLUSIVE DYSFUNCTION 97
Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. 96
30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM 96
[In Process Citation]. FT Doit-on porter des lunettes protectrices lors de l'utilisation du laser Holmium:YAG lors des procedures endourologiques? Etude chez un modele animal. 95
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 93
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 93
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 93
[Management of erectile dysfunction in patients with preexisting cardiovascular disease]. FT Disfunzione erettile nel paziente cardiopatico: diagnosi e raccomandazioni terapeutiche. 92
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer 91
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 91
Hyperestrogenism is associated with sexual function impairment in men-findings from a cross-sectional, real-life study 90
[Not Available]. FT Doit-on porter des lunettes protectrices lors de l'utilisation du laser Holmium:YAG lors des procedures endourologiques? Etude chez un modele animal. 90
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 90
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 90
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 90
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 89
Prediction of Sexual Function After Radical Prostatectomy 89
Pelvic lymph node dissection in prostate cancer 89
The Importance of Discordant Follicle Stimulating Hormone and Inhibin B Levels in Primary Infertile Men: Findings from a Cross-Sectional Study 88
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 87
[Management and prevention of catheter-associated urinary tract infections: current opinions and clinical practice]. FT Gestione e prevenzionedelle infezioni delle vieurinarie associate a catetere:opinioni e pratica clinica. 87
A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia 87
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 87
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 86
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 86
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 86
A global approach to improving penile cancer care 85
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 85
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 84
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 84
Long-term safety and tolerability of thdalafil in the treatment of erectile dysfunction 84
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 84
Medications mostly associated with priapism events: assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries 83
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 83
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 82
Prediction of Functional Outcomes After Nerve-Sparing Radical Prostatectomy: Results of Conditional Survival Analyses 82
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease 81
ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility 81
Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study 81
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 80
Correlation among isolated teratozoospermia, sperm DNA fragmentation and markers of systemic inflammation in primary infertile men 80
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 80
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 79
Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center 79
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 78
PROSTATIC UROLUME WALLSTENT FOR BENIGN PROSTATIC HYPERPLASIA PATIENTS AT POOR OPERATIVE RISK - CLINICAL, UROFLOWMETRIC AND ULTRASONOGRAPHIC PATTERNS 78
How to Select the Optimal Candidates for Renal Mass Biopsy 78
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 77
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 77
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 76
A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies 76
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 76
Haemospermia in the Real- Life Setting: A New High-Risk Stratification 76
[Not Available]. FT Second-look precoce par ureteroscopie souple apres traitement endoscopique conservatif pour tumeur de la voie excretrice urinaire superieure: resultats preliminaires. 76
Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate in Patients Under Either Anticoagulation or Antiplatelet Therapy 76
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 75
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 75
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 75
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 74
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 74
A critical analysis of vardenafil in the management of patients with erectile dysfunction: an integration of the literature and collective personal experience. 74
Totale 13.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 769.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 769.445
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 124 8 2 11 6 8 2
2021/20221.273 1 58 30 577 61 65 90 75 42 69 55 150
2022/202310.126 4.873 1.738 601 119 68 1.013 434 606 272 96 151 155
2023/20245.160 235 279 399 356 413 922 292 508 90 383 562 721
2024/202529.158 4.249 726 542 672 691 2.350 4.169 2.213 5.247 4.330 1.813 2.156
2025/202639.931 5.690 7.391 7.341 12.527 5.552 1.430 0 0 0 0 0 0
Totale 86.405